Publication | Closed Access
Phase I Clinical Trial of Recombinant Human Interleukin-3 Combined With Carboplatin in the Treatment of Patients With Recurrent Ovarian Carcinoma
13
Citations
0
References
1993
Year
MedicineImmunologyRecurrent Ovarian CarcinomaGynecologyImmune Checkpoint InhibitorCancer TreatmentOncologyGynecology OncologyOvarian Cancer
No additional data available for this publication yet. Check back later!